Skip to main content
. 2014 Oct 30;6(5):1190–1200. doi: 10.4161/mabs.29889

Table 1.

Site-specific antibody-drug conjugation on N-glycan of Fc does not affect the antibody binding activity to FcγRI and FcγRIIIa

  ka[1/Ms]
kd[1/s]
KD[M]
Antibody FcγRI FcγRIIIa FcγRI FcγRIIIa FcγRI FcγRIIIa
m860 IgG1 4.5E+4 1.1E+4 0.001007 0.01608 2.2E-8 1.5E-6
m860ADC 4.4E+4 0.9E+4 0.001078 0.01752 2.5E-8 1.9E-6
Control IgG1 7.6E+4 2.2E+4 0.001372 0.01484 1.8E-8 6.7E-7